Interferon-gamma in multiple myeloma

A Palumbo1, B Bruno, M Boccadoro

  • 1Dipartimento di Medicina e Oncologia Sperimentale, Università di Torino, Ospedale Molinette, Italy.

Leukemia & Lymphoma
|July 1, 1995
PubMed

Insights

Interferon-gamma (IFN-gamma) effectively inhibits multiple myeloma cell proliferation by targeting the key growth factor, Interleukin-6 (IL-6). This finding supports further in vivo studies for potential new cancer therapies.

Area of Science:

  • Oncology
  • Immunology
  • Hematology

Background:

  • Multiple myeloma exhibits biological heterogeneity, influenced by a complex cytokine network.
  • Cytokines play a crucial role in regulating plasma cell growth and tumor progression in multiple myeloma.
  • Interleukin-6 (IL-6) is recognized as a central growth factor for myeloma cells.

Purpose of the Study:

  • To investigate the antiproliferative effects of Interferon-gamma (IFN-gamma) on multiple myeloma cells.
  • To explore the mechanism of IFN-gamma's action, particularly its impact on IL-6 signaling.
  • To compare the efficacy of IFN-gamma with other agents like Interferon-alpha (IFN-alpha) and dexamethasone (DEX).

Main Methods:

  • In vitro proliferation assays using IL-6 dependent and independent myeloma cell lines.
  • Assessment of IFN-gamma's effect on fresh explanted bone marrow myeloma cells.
  • Evaluation of immunoglobulin (Ig) secretion and potential differentiating activity.

Main Results:

  • IFN-gamma demonstrated potent inhibition of myeloma cell proliferation, comparable to dexamethasone (DEX).
  • The antiproliferative effect of IFN-gamma was primarily attributed to the inhibition of IL-6.
  • IFN-alpha inhibited Ig secretion, while combined interferons (IFNs) affected both proliferation and Ig synthesis, mirroring DEX effects.
  • IFN-gamma also showed potential differentiating activity, augmenting monoclonal immunoglobulin secretion in some cases.

Conclusions:

  • IFN-gamma exhibits significant in vitro antitumor activity against multiple myeloma cells.
  • The inhibition of IL-6 is a key mechanism underlying IFN-gamma's antiproliferative effects.
  • These findings provide a strong rationale for evaluating the in vivo therapeutic potential of IFN-gamma in multiple myeloma.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...